Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Double-blind Period	STARTED	Placebo/KAD-1229	60
Double-blind Period	STARTED	KAD-1229/KAD-1229	118
Double-blind Period	COMPLETED	Placebo/KAD-1229	57
Double-blind Period	COMPLETED	KAD-1229/KAD-1229	114
Double-blind Period	NOT COMPLETED	Placebo/KAD-1229	3
Double-blind Period	NOT COMPLETED	KAD-1229/KAD-1229	4
Open-label Period	STARTED	Placebo/KAD-1229	57
Open-label Period	STARTED	KAD-1229/KAD-1229	113
Open-label Period	COMPLETED	Placebo/KAD-1229	50
Open-label Period	COMPLETED	KAD-1229/KAD-1229	88
Open-label Period	NOT COMPLETED	Placebo/KAD-1229	7
Open-label Period	NOT COMPLETED	KAD-1229/KAD-1229	25

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02154347/flow